We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+18.87%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$137M
AUM Growth
+$16.5M
Cap. Flow
+$772K
Cap. Flow %
0.56%
Top 10 Hldgs %
68.51%
Holding
147
New
47
Increased
29
Reduced
15
Closed
34

Top Buys

Rank Stock Value
1
DLPH
Delphi Technologies PLC Ordinary Shares
DLPH
+$3.12M
2
LVGO
Livongo Health, Inc. Common Stock
LVGO
+$3.04M
3
MXIM
Maxim Integrated Products
MXIM
+$2.88M
4
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$2.01M
5
STRO icon
Sutro Biopharma
STRO
+$611K

Top Sells

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$7.91M
2
CZR
Caesars Entertainment Corporation
CZR
+$4.15M
3
LOGM
LogMein, Inc.
LOGM
+$2.89M
4
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$548K
5
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$505K

Sector Composition

Rank Sector Weight
1 Technology 36.76%
2 Healthcare 21.07%
3 Financials 13.05%
4 Consumer Discretionary 10.17%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BZH icon
76
Beazer Homes USA
BZH
$875M
$136K 0.1%
+10,300
New +$120K
TPCO
77
DELISTED
Tribune Publishing Company Common Stock
TPCO
$131K 0.1%
11,200
– –
RYZ
78
Ryerson Holding Corp
RYZ
$1.46B
$104K 0.08%
18,100
+5,700
+46% +$33.1K
FRST icon
79
Primis Financial Corp
FRST
$409M
$100K 0.07%
+11,500
New +$101K
SURF
80
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$97K 0.07%
+14,000
New +$84.9K
IMGN
81
DELISTED
Immunogen Inc
IMGN
$96K 0.07%
+26,800
New +$108K
FPRX
82
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$96K 0.07%
+20,500
New +$104K
KDMN
83
DELISTED
Kadmon Holdings, Inc.
KDMN
$93K 0.07%
23,700
-60,912
-72% -$256K
AGEN
84
Agenus
AGEN
$317M
$92K 0.07%
1,167
+342
+41% +$26.6K
APTX
85
DELISTED
Aptinyx Inc. Common Stock
APTX
$88K 0.06%
+26,000
New +$99.7K
CTMX icon
86
CytomX Therapeutics
CTMX
$747M
$86K 0.06%
+13,000
New +$96.4K
BCRX icon
87
BioCryst Pharmaceuticals
BCRX
$2.59B
$85K 0.06%
+24,800
New +$106K
BDSI
88
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$84K 0.06%
22,600
+11,800
+109% +$50.2K
AFMD
89
DELISTED
Affimed
AFMD
$82K 0.06%
2,420
+320
+15% +$12.1K
LAB icon
90
Standard BioTools
LAB
$306M
$82K 0.06%
+11,000
New +$75.9K
VBIV
91
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$82K 0.06%
+953
New +$111K
UTI icon
92
Universal Technical Institute
UTI
$1.44B
$78K 0.06%
+15,300
New +$108K
CDMO
93
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$78K 0.06%
10,300
– –
VXRT
94
DELISTED
Vaxart
VXRT
$77K 0.06%
+11,600
New +$103K
NPTN
95
DELISTED
NEOPHOTONICS CORP
NPTN
$77K 0.06%
+12,700
New +$96.9K
LUNA
96
DELISTED
Luna Innovations Incorporated
LUNA
$77K 0.06%
+12,900
New +$76.4K
RBBN icon
97
Ribbon Communications
RBBN
$361M
$76K 0.06%
19,700
– –
RIGL icon
98
Rigel Pharmaceuticals
RIGL
$788M
$76K 0.06%
3,180
-840
-21% -$20.6K
AGTC
99
DELISTED
Applied Genetic Technologies Corporation
AGTC
$74K 0.05%
+15,200
New +$83K
LYTS icon
100
LSI Industries
LYTS
$928M
$73K 0.05%
+10,800
New +$69.8K
2 3
4
5 6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2020 Portfolio in Review

As of Q3 2020, HighVista Strategies held 147 positions worth $137M, up 14% from $121M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

HighVista Strategies's Q3 2020 filing shows 47 new, 29 increased, 15 reduced and 34 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M. The largest sale was Tech Data Corp, an estimated $7.91M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q3 2020 buy was Delphi Technologies PLC Ordinary Shares: 189,132 shares worth $3.16M.
  • HighVista Strategies added most to Xenon Pharmaceuticals in Q3 2020, an estimated $274K increase.
  • HighVista Strategies's biggest Q3 2020 reduction was Kadmon Holdings, Inc., cutting an estimated $256K.
  • HighVista Strategies fully exited Tech Data Corp in Q3 2020, selling an estimated $7.91M.
  • HighVista Strategies's ten largest holdings make up 69% of its $137M portfolio in Q3 2020.
  • HighVista Strategies opened 47 new positions and closed 34 in Q3 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $137M.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.